These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 498534)

  • 41. Detection of Duchenne muscular dystrophy carriers: quantitative echography and creatine kinasemia.
    Schapira G; Laugier P; Rochette J; Berger G; Katz P; Perrin J
    Hum Genet; 1987 Jan; 75(1):19-23. PubMed ID: 3542803
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The female carrier of Duchenne muscular dystrophy.
    Dubowitz V
    Br Med J (Clin Res Ed); 1982 May; 284(6327):1423-4. PubMed ID: 6805547
    [No Abstract]   [Full Text] [Related]  

  • 43. [A study on the serum biochemistry in carrier detection of Duchenne muscular dystrophy].
    Xie B
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Jun; 24(3):165-8, 189. PubMed ID: 1889329
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of serum creatine kinase, pyruvate kinase, and genetic linkage for carrier detection in Duchenne and Becker dystrophy.
    Hyser CL; Griggs RC; Mendell JR; Polakowska R; Quirk S; Brooke MH; Fenichel GM; Doherty RA
    Neurology; 1987 Jan; 37(1):4-10. PubMed ID: 2879259
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Computed tomographic findings in manifesting carriers of Duchenne muscular dystrophy.
    de Visser M; Verbeeten B
    Clin Genet; 1985 Mar; 27(3):269-75. PubMed ID: 3987077
    [TBL] [Abstract][Full Text] [Related]  

  • 46. DNA probes in Duchenne muscular dystrophy.
    Clayton J; Emery A
    Lancet; 1984 Nov; 2(8412):1151-2. PubMed ID: 6150202
    [No Abstract]   [Full Text] [Related]  

  • 47. Pregnancy and serum-creatine-kinase levels in potential carriers of Duchenne X-linked muscular dystrophy.
    Emery AE; King B
    Lancet; 1971 May; 1(7707):1013. PubMed ID: 4102421
    [No Abstract]   [Full Text] [Related]  

  • 48. [Estimation of the probability of heterozygosity in Duchenne-type progressive muscular dystrophy].
    Guízar Vázquez J; Navarrete Cadena C; Rico R; Mora G; Zavala C
    Bol Med Hosp Infant Mex; 1981; 38(1):23-33. PubMed ID: 7284070
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Creatine-kinase and pyruvate-kinase activities in normal children: implications in Duchenne muscular dystrophy carrier detection.
    Passos MR; Gonzalez CH; Zatz M
    Am J Med Genet; 1985 Oct; 22(2):255-62. PubMed ID: 4050856
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Estimates of conditional heterozygosity risks for young females in Duchenne muscular dystrophy.
    Passos-Bueno MR; Otto PA; Zata M
    Hum Hered; 1989; 39(4):202-11. PubMed ID: 2583732
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [A case of an 8-year-old girl, a symptomatic carrier of Duchenne's muscular dystrophy].
    Kurihara M; Imai Y; Kumagai K; Hasegawa H; Nonaka M
    No To Hattatsu; 1990 Jul; 22(4):394-6. PubMed ID: 2400617
    [No Abstract]   [Full Text] [Related]  

  • 52. The detection of carriers of benign (Becker-type) X-linked muscular dystrophy.
    Skinner R; Emery AE; Anderson AJ; Foxall C
    J Med Genet; 1975 Jun; 12(2):131-4. PubMed ID: 1142377
    [No Abstract]   [Full Text] [Related]  

  • 53. Estimate of the intrafamilial correlation for serum creatine kinase and pyruvate kinase in females at risk for Duchenne and Becker muscular dystrophies.
    Rabbi-Bortolini E; Dal Colletto GM; Passos-Bueno MR; Vainzof M; Rapaport D; Zatz M
    Hum Hered; 1991; 41(6):370-8. PubMed ID: 1797630
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Carrier detection in Duchenne muscular dystrophy.
    Fitzsimmons JS; McLachlan JI; Reeves WG; Marriott DW; Woolfson AM; Mayhew J
    J Med Genet; 1980 Jun; 17(3):165-9. PubMed ID: 7401126
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detection of carriers for Duchenne muscular dystrophy. Quality control of creatine kinase assay.
    Plauchu H; Junien C; Maire I; Said R; Gozlan R; Lalouel JM
    Hum Genet; 1982; 61(3):205-9. PubMed ID: 7173863
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The contribution of assays for lymphocyte capping and creatine kinase to detection of the Becker-type dystrophy trait.
    Goldsmith BM; Gruemer HD; Hawley RJ; Pickard NA; Verrill HL; Nance WE; Miller G; Crawford RG
    Clin Chem; 1980 May; 26(6):754-9. PubMed ID: 7371153
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Creatine phosphokinase activity in serum of carriers of progressive muscular dystrophy of Duchenne type].
    Barthelmai W; Dikbas G; Wüllner S
    Humangenetik; 1969 Oct; 8(2):115-33. PubMed ID: 5365581
    [No Abstract]   [Full Text] [Related]  

  • 58. [The use of discriminant analysis of serum creatine kinase levels for detection of heterozygote carriers of Duchenne muscular dystrophy].
    Krasil'nikov VV; Labeznik TA; Shilov LA
    Genetika; 1987 Jan; 23(1):176-9. PubMed ID: 3817468
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum creatine kinase studies in the detection of carriers of Duchenne dystrophy.
    Hughes RC; Park DC; Parsons ME; O'Brien MD
    J Neurol Neurosurg Psychiatry; 1971 Oct; 34(5):527-30. PubMed ID: 4941478
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Studies of the carrier state in the Duchenne type of muscular dystrophy. I. Effect of exercise on serum creatine kinase activity.
    Hudgson P; Gardner-Medwin D; Pennington RJ; Walton JN
    J Neurol Neurosurg Psychiatry; 1967 Oct; 30(5):416-9. PubMed ID: 6062992
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.